ABOUT RISEN
Risen Group
Corporate Culture
Development History
R&D Manangement Team
Partners
R&D
PIPELINE
CLINICAL
RP901
RP902
RP903
NEWS
Company news
IP granted
Publications
CONTACT US
CAREERS
Working at Risen
Job opportunities
Employee welfare
繁体
简体
RISEN PHARMA
ABOUT RISEN
Risen Group
Corporate Culture
Development History
Management Team
Partners
R&D
PIPELINE
CLINICAL
RP901
RP902
RP903
NEWS
Company news
IP granted
Publications
CONTACT US
CAREERS
Working at Risen
Job opportunities
Employee welfare
Company news
IP granted
Publications
2024-03-20
AACR 2024 Abstract #6050
Poster Download
2023-02-22
Discovery of Prodrug of MRTX1133 as an Oral Therapy for Cancers with KRASG12D Mutation
Detail
2022-12-12
A Dual-Specificity Inhibitor Targets Polyphosphate Kinase
Detail
Shanghai Zhangjiang R&D Center.
Suzhou Industrial Park R&D Center.
send mail
Copyright 2022 Risen(Shanghai) Pharma Tech Co., Ltd. All Rights Reserved
沪ICP备16020731号-1
Design by:
yushangweb